844 related articles for article (PubMed ID: 33476912)
1. The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.
Xu L; Xie X; Luo Y
Eur J Cell Biol; 2021 Mar; 100(2):151153. PubMed ID: 33476912
[TBL] [Abstract][Full Text] [Related]
2. Molecular Repolarisation of Tumour-Associated Macrophages.
van Dalen FJ; van Stevendaal MHME; Fennemann FL; Verdoes M; Ilina O
Molecules; 2018 Dec; 24(1):. PubMed ID: 30577495
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
Musick M; Yu X
Immunol Res; 2022 Aug; 70(4):432-440. PubMed ID: 35486115
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor-associated macrophages for cancer immunotherapy.
Cao X; Lai SWT; Chen S; Wang S; Feng M
Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
[TBL] [Abstract][Full Text] [Related]
5. Macrophage targeting in cancer.
Lopez-Yrigoyen M; Cassetta L; Pollard JW
Ann N Y Acad Sci; 2021 Sep; 1499(1):18-41. PubMed ID: 32445205
[TBL] [Abstract][Full Text] [Related]
6. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
Li L; Tian Y
Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
[TBL] [Abstract][Full Text] [Related]
7. Tumour-associated macrophages heterogeneity drives resistance to clinical therapy.
Guo S; Chen X; Guo C; Wang W
Expert Rev Mol Med; 2022 Apr; 24():e17. PubMed ID: 35400355
[TBL] [Abstract][Full Text] [Related]
8. Progress in tumor-associated macrophage (TAM)-targeted therapeutics.
Ngambenjawong C; Gustafson HH; Pun SH
Adv Drug Deliv Rev; 2017 May; 114():206-221. PubMed ID: 28449873
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
10. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.
Vanmeerbeek I; Govaerts J; Laureano RS; Sprooten J; Naulaerts S; Borras DM; Laoui D; Mazzone M; Van Ginderachter JA; Garg AD
Cells; 2022 Dec; 11(23):. PubMed ID: 36497148
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
12. Tailoring Nanomaterials for Targeting Tumor-Associated Macrophages.
Ovais M; Guo M; Chen C
Adv Mater; 2019 May; 31(19):e1808303. PubMed ID: 30883982
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
15. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy.
Liu L; Chen G; Gong S; Huang R; Fan C
Front Immunol; 2023; 14():1274547. PubMed ID: 38022518
[TBL] [Abstract][Full Text] [Related]
18. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
Jiang Y; Han Q; Zhao H; Zhang J
J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
[TBL] [Abstract][Full Text] [Related]
19. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
